ARTICLE | Clinical News
GSK stops aplaviroc trials
September 19, 2005 11:53 PM UTC
GlaxoSmithKline (LSE:GSK; GSK) stopped a placebo-controlled Phase II trial of aplaviroc (873140) in 250 treatment-naive HIV patients after two patients had an elevation in liver enzyme levels and bili...